Robaxin: Effective Muscle Spasm Relief and Pain Management
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.44 | $34.40 (0%) | 🛒 Add to cart |
| 20 | $1.94 | $68.80 $38.70 (44%) | 🛒 Add to cart |
| 30 | $1.43 | $103.20 $43.00 (58%) | 🛒 Add to cart |
| 60 | $0.79 | $206.40 $47.30 (77%) | 🛒 Add to cart |
| 90 | $0.57 | $309.60 $51.60 (83%) | 🛒 Add to cart |
| 120 | $0.50 | $412.80 $60.20 (85%) | 🛒 Add to cart |
| 180 | $0.43 | $619.20 $77.40 (88%) | 🛒 Add to cart |
| 270 | $0.38 | $928.80 $103.20 (89%) | 🛒 Add to cart |
| 360 | $0.36
Best per pill | $1238.40 $129.00 (90%) | 🛒 Add to cart |
Synonyms | |||
Robaxin (methocarbamol) is a centrally acting skeletal muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions. It works by blocking nerve impulses (or pain sensations) that are sent to the brain, helping to break the cycle of pain and muscle spasm. As an adjunct to rest, physical therapy, and other measures, it provides symptomatic relief, allowing for improved mobility and a faster return to normal function. Its efficacy and generally favorable side effect profile have made it a trusted option in clinical practice for decades.
Features
- Active Ingredient: Methocarbamol
- Available in 500 mg and 750 mg oral tablets
- Also available in injectable form for hospital use (Robaxin Injectable)
- Onset of action typically within 30 minutes of oral administration
- Not a controlled substance
- Generic versions are widely available
Benefits
- Provides rapid relief from acute musculoskeletal pain and spasm.
- Helps break the cycle of pain-spasm-pain, facilitating physical therapy and recovery.
- Reduces muscle stiffness and hypertonicity, improving range of motion.
- Allows for increased patient comfort and functional capacity during the healing process.
- Serves as a valuable adjunct to a comprehensive treatment plan including rest and physical modalities.
Common use
Robaxin is commonly prescribed for the symptomatic management of acute, painful musculoskeletal conditions. Its primary use is as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with these conditions. Typical scenarios include:
- Acute low back pain with associated muscle spasm.
- Post-traumatic or post-surgical muscle spasm.
- Sprains and strains.
- Torticollis (wry neck).
- Certain neurological conditions causing spasticity (though other agents are often first-line).
It is important to note that Robaxin is indicated for short-term use, typically not exceeding two or three weeks, due to a lack of evidence of its effectiveness in prolonged administration and the potential for associated complications.
Dosage and direction
Dosage must be individualized based on the patient’s severity of symptoms and response. The following are general guidelines for adults and children 16 years and older.
Initial dosage: An initial dose of 1500 mg (two 750 mg tablets or three 500 mg tablets) four times a day is recommended for the first 48 to 72 hours of treatment. For severe conditions, a dose of 8 grams per day may be administered for the first few days.
Maintenance dosage: Following the initial period, the dosage can usually be reduced to approximately 4000 to 4500 mg per day, administered in divided doses of 1000 mg (e.g., two 500 mg tablets) four times a day, or 1500 mg (e.g., two 750 mg tablets) three times a day.
Administration: Tablets should be taken orally with a full glass of water. They can be taken with or without food; taking with food may help minimize potential stomach upset.
Geriatric patients: Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy in this population, a dose reduction should be considered. Dosing should be cautious.
Duration of therapy: Use for longer than 2 or 3 weeks is not recommended (see Common Use).
Precautions
- Drowsiness/Dizziness: Robaxin may impair mental and/or physical abilities required for the performance of potentially hazardous tasks such as operating machinery or driving a motor vehicle. Patients should be cautioned accordingly.
- Renal Impairment: Methocarbamol is metabolized by the liver and its metabolites are excreted by the kidneys. Use with caution in patients with renal impairment, as this may lead to increased drug levels.
- Hepatic Impairment: Since the drug is metabolized by the liver, it should be used with caution in patients with hepatic impairment.
- Seizure Disorders: Use with caution in patients with a history of seizures, as methocarbamol may lower the seizure threshold.
- Pregnancy and Lactation: Robaxin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether methocarbamol is excreted in human milk; therefore, caution should be exercised if it is administered to a nursing woman.
- Pediatric Use: Safety and effectiveness in pediatric patients below the age of 16 have not been established.
Contraindications
Robaxin is contraindicated in patients with:
- A known hypersensitivity to methocarbamol or any components of the formulation.
- A history of allergic or anaphylactoid reactions to methocarbamol.
Possible side effect
The most frequently reported side effects are dose-related and often CNS-related. They are usually transient and may disappear with continued therapy or dose reduction.
- Very Common (≥10%): Dizziness, lightheadedness, drowsiness, nausea.
- Common (1-10%): Blurred vision, headache, fever, rash, urticaria (hives), flushing, gastrointestinal upset.
- Less Common (<1%): Nasal congestion, metallic taste, insomnia, confusion, bradycardia, hypotension, syncope, anaphylactic reaction, leukopenia. The injectable form may cause pain and sloughing at the injection site, phlebitis, and extravasation.
Drug interaction
- CNS Depressants: Methocarbamol may have additive sedative effects when used with alcohol, benzodiazepines (e.g., alprazolam, diazepam), opioids (e.g., hydrocodone, oxycodone), barbiturates, sedating antihistamines, or other sedative-hypnotics. Concomitant use requires caution and potentially lower doses of one or both agents.
- Pyridostigmine: Methocarbamol may antagonize the effects of pyridostigmine, a medication used for myasthenia gravis.
- MAO Inhibitors: While not a classic interaction, caution is advised due to the potential for enhanced CNS effects.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should not double the dose to “catch up.”
Overdose
Symptoms: Overdose of methocarbamol is characterized predominantly by CNS depression: drowsiness, lethargy, nausea, vomiting, coma, and seizures. Hypotension and bradycardia have also been reported. Management: Management involves symptomatic and supportive care. There is no specific antidote. Secure the airway and ensure adequate ventilation. Gastric lavage may be considered if performed soon after ingestion. Monitor cardiac function and vital signs. Seizures can be treated with benzodiazepines. Hemodialysis may be of value in severe overdose, but data is limited.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F).
- Protect from light and moisture.
- Keep in the original container, tightly closed.
- Keep out of reach of children and pets.
- Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on the drug’s prescribing information but may not be exhaustive.
Reviews
- “As a physical therapist, I often see patients in acute spasm. When prescribed appropriately, Robaxin can be a very effective tool to reduce pain and guarding, which allows us to begin active mobilization and therapeutic exercise much sooner. The sedative effect, while a downside for some, can be beneficial in allowing the muscle to truly relax.” – Medical Professional
- “I’ve prescribed methocarbamol for years for acute back spasms. It’s a well-tolerated option for many patients. The key is patient education regarding the high likelihood of drowsiness and the importance of short-term use only.” – Orthopedic Specialist
- “After a severe muscle strain, my doctor prescribed Robaxin. The drowsiness was significant for the first two days, but it effectively broke the intense spasm cycle. It made the difference between being completely immobile and being able to start gentle movement.” – Patient
- “It works well for what it’s designed for. The initial dose is high and will make you very sleepy, but that’s part of the therapeutic effect. It’s important to plan to not drive or operate machinery while taking it.” – Patient